Showcasing magAssist's Extracorporeal Support Solutions at 36th Annual ELSO Conference

From September 28 to 30, 2025, magAssist participated in the 36th Annual Meeting of the Extracorporeal Life Support Organization (ELSO), hosting a dedicated booth to present the MoyoAssist® - Extracorporeal VAD and the BreathMo® - Portable ECMO System. The event provided a platform for the company to engage with global experts, clinicians, and industry peers, exchanging insights on the clinical applications and future directions of extracorporeal life support.

The 36th Annual ELSO Conference, held at the Gaylord National Resort & Convention Center in Oxon Hill, Maryland, is one of the world's leading gatherings for specialists in cardiac surgery, intensive care, perfusion, and critical care. The conference featured discussions on the latest research, clinical practices, and technological innovations in the field.

At booth No. 327, magAssist presented two core technologies. 

• The MoyoAssist® is intended for use in tertiary hospitals, supporting acute heart failure, and complex cardiac surgeries. It helps maintain hemodynamic stability, supporting patient recovery and serving as a bridge to transplantation when needed. 

• The BreathMo®, a fully magnetically levitated device, offers enhanced hemocompatibility and is indicated for both extracorporeal ventricular assistance and extracorporeal membrane oxygenation.

  
  

During the conference, attendees showed interest in MoyoAssist® for its role in managing acute heart failure cases. The portable design and hemocompatibility features of BreathMo® also attracted attention from clinicians exploring advanced ECMO solutions. These discussions reflected the ongoing clinical demand for next-generation extracorporeal technologies and the relevance of magAssist's innovations in this field.

About ELSO

The Extracorporeal Life Support Organization (ELSO) is an international nonprofit consortium of healthcare institutions, researchers, providers, and industry partners. We provide support to those delivering extracorporeal life support through continuing education, guidelines, original research, publications, and a comprehensive registry of ECMO patient data.